David A. Cox

David A. Cox

Interventional Cardiology | Cardiology

10650 Park Road
Suite 220
Charlotte, NC 28210

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 145 publications

The Persistent Failure of Catheterization Laboratory Safety: Time for Enhanced Radiation Protection Devices.

The Persistent Failure of Catheterization Laboratory Safety: Time for Enhanced Radiation Protection Devices.

Journal: Journal of the Society for Cardiovascular Angiography & Interventions

Published: April 19, 2026

Sarcopenia: effects of Robuvit® supplementation on loss of muscular mass and strength.

Sarcopenia: effects of Robuvit® supplementation on loss of muscular mass and strength.

Journal: Minerva medica

Published: March 09, 2026

Challenges in shared decision-making about major lower limb amputation: the PERCEIVE qualitative study.

Challenges in shared decision-making about major lower limb amputation: the PERCEIVE qualitative study.

Journal: BMJ open

Published: January 12, 2026

Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial.

Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial.

Journal: Lancet (London, England)

Published: December 22, 2025

Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes. Reply.

Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes. Reply.

Journal: The New England journal of medicine

Published: December 03, 2025

The Evolution of Carotid Stenting-From Reason to Reality.

The Evolution of Carotid Stenting-From Reason to Reality.

Journal: Journal of the Society for Cardiovascular Angiography & Interventions

Published: October 23, 2025

Standards for Comparative Radiation Protection Research.

Standards for Comparative Radiation Protection Research.

Journal: Journal of the Society for Cardiovascular Angiography & Interventions

Published: September 17, 2025

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes.

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes.

Journal: The New England journal of medicine

Published: June 22, 2025

Pycnogenol® improves retinal microcirculation and symptoms of optic nerve ischemic damage after sudden, reversible unilateral loss of vision: a pilot evaluation.

Pycnogenol® improves retinal microcirculation and symptoms of optic nerve ischemic damage after sudden, reversible unilateral loss of vision: a pilot evaluation.

Journal: Journal of neurosurgical sciences

Published: May 27, 2025

Borderline hyperlipidemia: preventive supplementation with berberine phospholipids to prevent early atherosclerosis evolution.

Borderline hyperlipidemia: preventive supplementation with berberine phospholipids to prevent early atherosclerosis evolution.

Journal: Minerva medica

Published: April 24, 2025

Per- and polyfluoroalkyl substances (PFAS) in paired tap water and house dust from United States homes.

Per- and polyfluoroalkyl substances (PFAS) in paired tap water and house dust from United States homes.

Journal: Indoor environments

Published: April 04, 2025

Supplementation with Pycnogenol® relieves symptoms of chronic inflammatory diseases with a significant vasculitis component: a pilot registry study.

Supplementation with Pycnogenol® relieves symptoms of chronic inflammatory diseases with a significant vasculitis component: a pilot registry study.

Journal: Minerva medica

Published: March 31, 2025

Showing 1-12 of 145

Last Updated: 09/26/2026